Login / Signup

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients.

Benjamin UngarSusan HartzellDaniel Lozano-OjalvoSabrina GhaliliSwaroop BoseAlexandra K GolantKathryn TanYeriel D EstradaGiselle K SingerAna B PavelPaolo CravediEmma Guttman-Yassky
Published in: Allergy (2022)
Keyphrases
  • atopic dermatitis
  • sars cov
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • respiratory syndrome coronavirus
  • patient reported outcomes
  • coronavirus disease